My watch list  


Systematic (IUPAC) name
CAS number 50936-59-9
ATC code A16AB09
PubChem  ?
Chemical data
Formula  ?
Mol. mass  ?
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.


Legal status
Routes  ?

Idursulfase (brand name Elaprase) is a drug used to treat Hunter syndrome (also called Mucopolysaccharoidosis II).[1] It is a purified form of the lysosomal enzyme iduronate-2-sulfatase and is produced by recombinant DNA technology in a human cell line.

It is one of the most expensive drugs ever produced. Initial yearly costs were reported to be $300,000.[2]

It is manufactured by Shire Pharmaceuticals Group.


  1. ^ Garcia AR, DaCosta JM, Pan J, Muenzer J, Lamsa JC (2007). "Preclinical dose ranging studies for enzyme replacement therapy with idursulfase in a knock-out mouse model of MPS II". Mol. Genet. Metab. 91 (2): 183-90. doi:10.1016/j.ymgme.2007.03.003. PMID 17459751.
  2. ^ Drug approved to treat rare but potentially deadly disease. Retrieved on 2007-09-02.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Idursulfase". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE